Systemic lupus erythematosus (SLE or lupus) is a chronic disease that causes systemic inflammation and affects multiple organs. Is it possible to identify preclinical signs of SLE very early and intervene to prevent a patient’s transition to active disease? Who is most at risk to develop SLE, and why? How does a person transition from health to active lupus? Lupus flares vary from mild to serious. Most patients have times when the disease is active, followed by times when the disease is mostly quiet. How can we help patients achieve and maintain remission? These are some of the questions explored in sessions at ACR Convergence 2020 and that we’ve covered in the pages of The Rheumatologist in past issues.
Watch this space for Physician Editor Philip Seo, MD, MHS-selected coverage from ACR Convergence 2020, beginning with a report on the State of the Art: Lupus—the Future Is Now session, moderated by Saira Sheikh, MD. We also invite you to explore our collection of research reviews, case reports and clinical articles on advances in the diagnosis and management of SLE.